72 related articles for article (PubMed ID: 8795842)
1. Spinal muscular atrophy in childhood.
Fidziańska A
Semin Pediatr Neurol; 1996 Jun; 3(2):53-8. PubMed ID: 8795842
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of neuropathophysiology in spinal muscular atrophy type I.
Harding BN; Kariya S; Monani UR; Chung WK; Benton M; Yum SW; Tennekoon G; Finkel RS
J Neuropathol Exp Neurol; 2015 Jan; 74(1):15-24. PubMed ID: 25470343
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of three subtypes of spinal muscular atrophy in children.
Yuan P; Jiang L
Brain Dev; 2015 May; 37(5):537-41. PubMed ID: 25199871
[TBL] [Abstract][Full Text] [Related]
4. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
[TBL] [Abstract][Full Text] [Related]
5. Spinal Muscular Atrophy: Autopsy Based Neuropathological Demonstration.
Thirunavukkarasu B; Gupta K; Bansal A; Dhanasekaran N; Baranwal A
Neurol India; 2020; 68(4):882-885. PubMed ID: 32859833
[TBL] [Abstract][Full Text] [Related]
6. Association between SMN2 methylation and disease severity in Chinese children with spinal muscular atrophy.
Cao YY; Qu YJ; He SX; Li Y; Bai JL; Jin YW; Wang H; Song F
J Zhejiang Univ Sci B; 2016 Jan; 17(1):76-82. PubMed ID: 26739529
[TBL] [Abstract][Full Text] [Related]
7. Augmenting the SMN Protein to Treat Infantile Spinal Muscular Atrophy.
Kim JK; Monani UR
Neuron; 2018 Mar; 97(5):1001-1003. PubMed ID: 29518354
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype correlation of SMN locus genes in spinal muscular atrophy children from Argentina.
Medrano S; Monges S; Gravina LP; Alías L; Mozzoni J; Aráoz HV; Bernal S; Moresco A; Chertkoff L; Tizzano E
Eur J Paediatr Neurol; 2016 Nov; 20(6):910-917. PubMed ID: 27510309
[TBL] [Abstract][Full Text] [Related]
9. A paucisymptomatic neuromuscular disease mimicking type III 5q-SMA with complex rearrangements in the SMN gene.
Lohkamp LN; von Au K; Goebel HH; Kress W; Grieben U; Drossel K; Garbes L; Wirth B; Heppner FL; Stenzel W
J Child Neurol; 2014 Feb; 29(2):254-9. PubMed ID: 24334346
[TBL] [Abstract][Full Text] [Related]
10. Monitoring spinal muscular atrophy with three-dimensional optoacoustic imaging.
Nedoschill E; Wagner AL; Danko V; Buehler A; Raming R; Jüngert J; Neurath MF; Waldner MJ; Rother U; Woelfle J; Trollmann R; Knieling F; Regensburger AP
Med; 2024 May; 5(5):469-478.e3. PubMed ID: 38531362
[TBL] [Abstract][Full Text] [Related]
11. Reorganization of the nuclear compartments involved in transcription and RNA processing in myonuclei of type I spinal muscular atrophy.
Castillo-Iglesias MS; Berciano MT; Narcis JO; Val-Bernal JF; Rodriguez-Rey JC; Tapia O; Lafarga M
Histochem Cell Biol; 2019 Sep; 152(3):227-237. PubMed ID: 31183542
[TBL] [Abstract][Full Text] [Related]
12. Two Japanese Patients With SMA Type 1 Suggest that Axonal-SMN May Not Modify the Disease Severity.
Yamada H; Nishida Y; Maihara T; Sa'adah N; Harahap NI; Nurputra DK; Ar Rochmah M; Nishimura N; Saito T; Kubo Y; Saito K; Nishio H
Pediatr Neurol; 2015 Jun; 52(6):638-41. PubMed ID: 25838041
[TBL] [Abstract][Full Text] [Related]
13. Infantile spinal muscular atrophy (SMA).
Chabrol B; Desguerre I
Arch Pediatr; 2020 Dec; 27(7S):7S1-7S2. PubMed ID: 33357590
[No Abstract] [Full Text] [Related]
14. Association between spinal muscular atrophy type and delayed diagnosis and the risk of spinal deformity in Indonesian patients.
Sari DM; Biben V; Wiwaha G; Hilmanto D
Eur J Med Res; 2023 Mar; 28(1):130. PubMed ID: 36941660
[TBL] [Abstract][Full Text] [Related]
15. Functional and surgical treatments in patients with spinal muscular atrophy (SMA).
Boulay C; Peltier E; Jouve JL; Pesenti S
Arch Pediatr; 2020 Dec; 27(7S):7S35-7S39. PubMed ID: 33357596
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of spinal muscular atrophy (SMA) type 2.
Cancès C; Richelme C; Barnerias C; Espil C
Arch Pediatr; 2020 Dec; 27(7S):7S18-7S22. PubMed ID: 33357592
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care.
Mercuri E; Finkel RS; Muntoni F; Wirth B; Montes J; Main M; Mazzone ES; Vitale M; Snyder B; Quijano-Roy S; Bertini E; Davis RH; Meyer OH; Simonds AK; Schroth MK; Graham RJ; Kirschner J; Iannaccone ST; Crawford TO; Woods S; Qian Y; Sejersen T;
Neuromuscul Disord; 2018 Feb; 28(2):103-115. PubMed ID: 29290580
[TBL] [Abstract][Full Text] [Related]
18. Observations from a nationwide vigilance program in medical care for spinal muscular atrophy patients in Chile.
Alvarez K; Suarez B; Palomino MA; Hervias C; Calcagno G; Martínez-Jalilie M; Lozano-Arango A; Lillo S; Haro M; Cortés F; Pantoja S; Chahin A; Orellana P; Bevilacqua JA; Bertini E; Castiglioni C
Arq Neuropsiquiatr; 2019 Jul; 77(7):470-477. PubMed ID: 31365638
[TBL] [Abstract][Full Text] [Related]
19. [Spinal muscular atrophy treated with nusinersen].
Boesen MS; Albrechtsen S; Born AP
Ugeskr Laeger; 2019 Jan; 181(2):. PubMed ID: 30618374
[TBL] [Abstract][Full Text] [Related]
20. PLS3 expression and SMA phenotype: a commentary on correlation of PLS3 expression with disease severity in children with spinal muscular atrophy.
Nishio H
J Hum Genet; 2014 Feb; 59(2):64-5. PubMed ID: 24284364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
